These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. On the pathogenetic role of prostaglandins in Bartter's syndrome. Nielsen I, Hesse B, Christensen P. Acta Med Scand Suppl; 1979; 625():135-40. PubMed ID: 285569 [Abstract] [Full Text] [Related]
11. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism? Donker AJ, de Jong PE, van Eps LW, Brentjens JR, Bakker K, Doorenbos H. Nephron; 1977; 19(4):200-13. PubMed ID: 917167 [Abstract] [Full Text] [Related]
14. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis]. Favre L, Glasson P, Flory ED, Dray F, Vallotton MB. Schweiz Med Wochenschr; 1979 Feb 03; 109(5):142-7. PubMed ID: 441720 [Abstract] [Full Text] [Related]
15. Interrelation between renal prostaglandins and the hormones involved in volume homeostasis by the kidney. Glasson P, Vallotton MB. Clin Exp Hypertens (1978); 1980 Feb 03; 2(3-4):761-75. PubMed ID: 7000470 [Abstract] [Full Text] [Related]
16. Renal prostaglandins. Terragno NA, Malik KU, Nasjletti A, Terragno DA, McGiff JC. Adv Prostaglandin Thromboxane Res; 1976 Feb 03; 2():561-71. PubMed ID: 824936 [Abstract] [Full Text] [Related]
17. Effect of indomethacin on urinary kallikrein excretion in Bartter's syndrome of the adult. Lechi A, Mantero F, Opocher G, Armanini D, Lechi C, Covi G. J Endocrinol Invest; 1981 Feb 03; 4(1):17-20. PubMed ID: 7016967 [Abstract] [Full Text] [Related]